Genome-wide fine-mapping improves identification of causal variants.

Area of Science:

• Genetics
• Genomics
• Statistical Genetics

Background:

• Fine-mapping refines genotype-phenotype associations to pinpoint causal variants.
• Current methods often analyze genomic segments in isolation, neglecting global genetic architecture.

Purpose of the Study:

• Demonstrate the benefits of genome-wide fine-mapping (GWFM).
• Develop novel methods to enable and facilitate GWFM.
• Improve the accuracy and scope of causal variant identification for complex traits.

Main Methods:

• Developed and applied genome-wide fine-mapping (GWFM) methods.
• Evaluated GWFM performance through simulations and real-world data analysis (UK Biobank).
• Integrated functional annotations for enhanced variant analysis.

Main Results:

• GWFM demonstrated superior error control, mapping power, precision, and replication rates compared to existing methods.
• Identified causal variants explaining 17% of SNP-based heritability for 48 complex traits.
• Uncovered a secondary variant at FTO for body mass index and identified novel missense causal variants for schizophrenia and Crohn's disease.

Conclusions:

• Genome-wide fine-mapping (GWFM) offers significant advantages over traditional fine-mapping techniques.
• GWFM enhances the discovery and characterization of causal variants across numerous complex traits.
• The approach holds promise for future genetic studies requiring large sample sizes and comprehensive analysis.